Palo Alto, CA, United States of America

Erick T Engelson

This inventor holds 1 USPTO granted patent. Top assignee: Target Therapeutics, Inc.. Active years: 1989.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 326(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Erick T Engelson

Introduction

Erick T Engelson is a notable inventor based in Palo Alto, CA. He has made significant contributions to the field of medical devices, particularly with his innovative catheter technology. His work has the potential to enhance medical procedures and improve patient outcomes.

Latest Patents

Erick T Engelson holds a patent for a valved catheter device and method. This catheter device is designed for accessing internal body sites along small-diameter vessel paths that contain branch points. The device features a catheter with a distal-end inflatable balloon and a distal-end aperture. A guide wire within the device is engineered to block the aperture at various axial wire positions, allowing for the inflation of the balloon through fluid infusion into the catheter. This innovative design facilitates catheter placement operations by enabling the catheter to navigate through complex vascular pathways.

Career Highlights

Erick Engelson is currently associated with Target Therapeutics, Inc., where he continues to develop and refine medical technologies. His expertise in catheter design and functionality has positioned him as a valuable asset in the medical device industry.

Collaborations

One of his notable collaborators is John R Daniels, with whom he has worked on various projects aimed at advancing catheter technology.

Conclusion

Erick T Engelson's contributions to the field of medical devices, particularly through his patented valved catheter device, demonstrate his commitment to innovation and improving healthcare solutions. His work continues to influence the medical community positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…